MAPK1 and breast cancer: Cell experiments showed that BC could inhibit the Ras/ERK/c-Fos signaling pathway while downregulating HSP90AA1 expression and upregulating PTGS2 expression, thereby promoting apoptosis, causing S-phase cycle arrest, and inhibiting the proliferation and migration of BT549 cells.